The European Federation of Industries and Associations (EFPIA) has welcomed the European Commission's newly published ...
The European pharma body’s new Health Collaboration Guide hopes to inspire greater partnership working across healthcare, showcasing award-winning collaborations involving Pfizer, Janssen, Novartis ...
It’s difficult to open an email or an envelope in Brussels these days without yet another agenda falling out of it, carrying the promise of a new start. It’s difficult to open an email or an envelope ...
European pharmaceutical trade body EFPIA has said that patient access to new medicines is worsening across the continent, as it makes the socioeconomic case for spending more on innovative drugs. In ...
Pharmaceutical Technology on MSN
EU pharma industry pushes for expansion of barcodes on medicines
The EAHP and EFPIA want all individual doses to carry a barcode, an addition they say will further reduce medication errors.
The Council of the European Union has delivered its newest set of proposals meant to shake up European pharma regulations and sharpen the region's competitive edge, but the plan isn't exactly what EU ...
The European Federation of Pharmaceutical Industries and Associations (EFPIA), the trade association representing European pharmaceutical manufacturers, issued recommendations to the public ...
For some time, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has been working on developing a European verification system to help combat falsified medicines. For some ...
The association for the research-based pharmaceutical industry in Europe has challenged on ethical, legal and technical grounds the EMA’s draft policy on publication of, and access to, clinical-trial ...
The European Commission’s draft Pharmaceutical Legislation could cost Europe about one-third of its share of global research and development (R&D) by 2040, according to the European Federation of ...
Big pharma trade group EFPIA has called on the European Commission to create a multi-stakeholder forum to discuss how to improve access to medicines. The proposal comes shortly after EFPIA voiced its ...
Industry's grand vision for reshaping the life sciences in Europe may ultimately prove to be a lost cause. It's difficult to open an email or an envelope in Brussels these days without yet another ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results